Kornitzer Benjamin's Form 4/A amendment
Amendedagilon health, inc. (AGL) · filed Jan 9, 2023
- Accession no.
- 0001209191-23-002592
- Filed
- Jan 9, 2023
- Trade date
- Dec 16, 2022
- Filing delay
- 24 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Dec 19, 2022
This filing lists 2 non-derivative transactions and 2 derivative transactions. It carries over 4 transactions from the original filing that it did not restate. Open-market sales total $184.8K. It was filed 24 days after the trade.
This amendment restates part of 0001209191-22-061925 (filed Dec 19, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kornitzer BenjaminCIK 0001855842 | Officer (Chief Med. & Quality Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | Common Stock | MOption exerciseAcquired | +4,511 | $4.49 | +$20,254.39 | 14,937 | Direct | |
| Dec 16, 2022 | Common Stock | MOption exerciseAcquired | +887 | $8.99 | +$7,974.13 | 15,824 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | Common Stock | MOption exerciseDisposed | −4,511 | $0.00 | $0 | 275,000 | Direct | |
| Dec 16, 2022 | Common Stock | MOption exerciseDisposed | −887 | $0.00 | $0 | 249,113 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-22-061925 (filed Dec 19, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | Common Stock | MOption exerciseAcquired | +5,398 | $4.49 | +$24,237.02 | 15,824 | Direct | |
| Dec 15, 2022 | Common Stock | SSaleDisposed | −5,398 | $17.42F3 | −$94,033.16 | 10,426 | Direct | |
| Dec 16, 2022 | Common Stock | SSaleDisposed | −5,398 | $16.82F4 | −$90,794.36 | 10,426 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | Common Stock | MOption exerciseDisposed | −5,398 | $0.00 | $0 | 279,511 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.39 to $17.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.72 to $17.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Includes restricted stock units.
- F2
These options were granted on January 31, 2020 and vest in four equal installments on January 31 of each of 2021, 2022, 2023, and 2024.
- F3
These options were granted on January 31, 2020 and vested on September 14, 2021.
Remarks
This Form 4 Amendment corrects the tranche of 887 vested options exercised by the Reporting Filer as reported on the Form 4 filed on December 19, 2022.